|
|
Article: CLX Medical, Inc. to License Additional Point-of-Care Diagnostic Testing Devices and the Outcome of the HandiLab-C Chlamydia Laboratory Study.
- Article from:
- M2 Presswire
- Article date:
- October 16, 2008
CopyrightCOPYRIGHT 2008 M2 Communications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-16 October 2008-InvestSource, Inc.: CLX Medical, Inc. to License Additional Point-of-Care Diagnostic Testing Devices and the Outcome of the HandiLab-C Chlamydia Laboratory Study(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:16102008
Stocks in the news: CLX Medical, Inc. (OTC BB:CLXN.OB), Heart Health, Inc. (Other OTC:HHEL.PK), Volcano Corporation (Nasdaq: VOLC), FONAR Corporation (NasdaqCM:FONR),
October 15, 2008 -- CLX Medical, Inc. (OTC BB:CLXN.OB), which is focused on the marketing and distribution of unique medical diagnostic testing products, today announced a letter of intent to license additional medical diagnostic testing devices ...
Related newspaper, magazine, and journal articles:
|
|
Article: CLX Medical, Inc. Announces Close of ThyroTest(R) ...
Internet Wire;
December 2, 2008 ;
700+ words
... ... 2008 (MARKET WIRE via COMTEX) -- CLX Medical, Inc. (OTCBB: CLXN), which is ... With the close of the transaction, CLX Medical will implement its ThyroTest(R) marketing ... waived laboratory. Vera Leonard, CEO of CLX Medical, stated, "We have already begun the ...
|
|